Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ciliogenesis and planar polarity effector complex subunit 2 (CPLANE2) is a protein encoded by the CPLANE2 gene, with key roles in the assembly and initiation of primary cilia, as well as the regulation of planar cell polarity signaling[2][11][1]. It functions as a Ras-related GTPase and is required for a late step in primary cilia initiation, contributing to the final maturation of the mother centriole and ciliary vesicle that permits the extension of the ciliary axoneme[2][11][1][10]. Defects in CPLANE2 are associated with developmental disorders such as Joubert syndrome and Carpenter syndrome[2]. The protein is localized to the centriole, ciliary basal body, and ciliary transition zone, and is involved upstream of processes like axoneme assembly, endocardial cushion fusion, and smoothened signaling regulation[2][9][6]. As of now, CPLANE2 is not considered a direct therapeutic target, and there are no known drugs or established mechanisms of action targeting this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliogenesis and planar polarity effector complex subunit 2 (CPLANE2).